CareStart™ Products
Our full range of COVID-19 testing solutions enables testing in different settings to fulfill the diagnostic needs of healthcare providers and patients. The COVID-19 antigen test and our molecular test (MDx RT-PCR) help detect acute or persistent infection, while our serology test (COVID-19 IgM/IgG) helps detect antibodies that show recent or past infection.
CareStart™ COVID-19 Antigen Test
The CareStart™ Covid-19 Antigen test is affordable, consistent, and easy-to-use, with results in 10 minutes. CareStart™ Antigen is now approved for use with lower nasal swabs (anterior nares). To accommodate the tremendous demand of this test, Intrivo is continuing to quickly expand our production capacity.
All available CareStart™ COVID-19 tests have received Emergency Use Authorization (EUA) by the FDA.
Intrivo:
Where Innovation Meets Purpose
As a digital health company, our mission is to combine intuitive tools with comprehensive health information to steward patients from triage to recovery and sustained wellness. Serving as the exclusive US commercialization partner for access bio, we are providing sophisticated, accessible, and accurate testing solutions for COVID-19 to fit your organization’s needs.